COCP News and Press, Cocrystal Pharma Inc. From 11/01/21

Cocrystal Pharma (NASDAQ:COCP) has added ~5.5% in the pre-market after the company disclosed the submission of a pre-Investigational New Drug (IND) briefing package to the FDA seeking to advance its experimental protease inhibitor CDI-45205 for the treatment of COVID-19. “We look ...

FDA ’s response is expected to provide greater clarity and guidance on designing Phase 1 and Phase 2 clinical trials for CDI-45205 BOTHELL, Wash., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COC...

BOTHELL, Wash., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage company discovering and developing novel antiviral therapeutics, announces that President and co-interim CEO Dr. Sam L...

BOTHELL, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of...

BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machiner...

BOTHELL, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company, announces that management will present at the 23 rd Annual Global Investment Conference being...

Penny Stocks Insiders Are Scooping Up Is there a secret to finding the best penny stocks to buy right now? If you ask some traders, they’ll tell you to follow the money. But what does that actually mean? This entails following big trades made in the market & that goes for bot...

Cocrystal Reports 2Q21 With Clinical Trial Milestones Cocrystal Pharmaceuticals reported 2Q21 results of a loss of $3.8 million or $(0.04) per share, compared with our expected loss of $3.1 million or (0.04) per share. Differences from our estimates were largely due to higher Research expenses...

With the number of new COVID cases surging, fueled by a highly contagious Delta variant and only 50% of the US population having been vaccinated,  rapid COVID tests and treatments are more important than ever. Perhaps even more alarming is the fact that the Centers for Di...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 19, 2021 – With the number of new COVID cases surging, fueled by a highly contagious Delta variant and only 50% of the US population having been vaccinated, the need for rapid tes...